CN114457102B - Gene expression cassette for encoding secreted Mersacidin and preparation method thereof - Google Patents

Gene expression cassette for encoding secreted Mersacidin and preparation method thereof Download PDF

Info

Publication number
CN114457102B
CN114457102B CN202210173000.6A CN202210173000A CN114457102B CN 114457102 B CN114457102 B CN 114457102B CN 202210173000 A CN202210173000 A CN 202210173000A CN 114457102 B CN114457102 B CN 114457102B
Authority
CN
China
Prior art keywords
gene
mersacidin
primer
encoded
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202210173000.6A
Other languages
Chinese (zh)
Other versions
CN114457102A (en
Inventor
黄金秀
苏国旗
杨飞云
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chongqing Academy of Animal Sciences
Original Assignee
Chongqing Academy of Animal Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chongqing Academy of Animal Sciences filed Critical Chongqing Academy of Animal Sciences
Priority to CN202210173000.6A priority Critical patent/CN114457102B/en
Publication of CN114457102A publication Critical patent/CN114457102A/en
Application granted granted Critical
Publication of CN114457102B publication Critical patent/CN114457102B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/75Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention belongs to the field of genetic engineering, and in particular relates to a gene expression cassette for encoding secreted Mersacidin and a preparation method thereof. The invention discloses a gene expression cassette for encoding secreted Mersacidin, the nucleotide sequence of which is shown as SEQ ID NO. 1. The invention utilizes high-fidelity enzyme to amplify the mrsK2R2FGE, mrAR 1D and mrMT of Mersacidin gene cluster genes mrsK2R2FGEAR1DMT, and utilizes Gibson cloning technology to connect the 3 segments of Mersacidin gene cluster genes to construct a Mersacidin expression cassette, the expression cassette is placed at the downstream of a strong promoter, and the Mersacidin expression cassette is introduced into genetic engineering bacteria Bacillus subtilisSCK to realize the efficient secretion expression of Mersacidin, thereby providing a cheap biological antibacterial agent and preservative for feed additives, veterinary drugs, foods and medicines.

Description

Gene expression cassette for encoding secreted Mersacidin and preparation method thereof
Technical Field
The invention belongs to the field of genetic engineering, and in particular relates to a gene expression cassette for encoding secreted Mersacidin and a preparation method thereof.
Technical Field
Bacteriocins are polypeptides or precursor polypeptides synthesized by the bacteria through ribosomes in the metabolic process, have ideal probiotic characteristics, have the functions of effectively inhibiting pathogens, regulating inflammation, promoting wound healing, protecting mucous membrane and the like, and are not easy to generate drug resistance.
Mersacidin was produced by Bacillus HIL Y-8554728, 20aa long, belonging to class Ib bacteriocins. The Mersacidin is pure white amorphous powder, stable at the ambient temperature, stable at pH 5.0-7.0 and insoluble in water; the metal salt is easily soluble in water and can enhance its bactericidal activity. Mersacidin inhibits the transglycosylation reaction of peptidoglycan biosynthesis by forming a complex with the glycophosphoric acid group of peptidoglycan precursor lipid II, thereby inhibiting cell wall synthesis and killing microorganisms. Merdacidin has an MIC of 1-32 mug/mL for methicillin-resistant staphylococcus aureus (MRSA), 0.5-16 mug/mL for methicillin-resistant staphylococcus epidermidis, 0.5-8 mug/mL for streptococcus, and 0.5-8 mug/mL for clostridium perfringens. Although Mersacidin had a MIC for MRSA greater than vancomycin, mice challenged with MRSA (st. Aureus E710) were treated subcutaneously with 25mg/kg Mersacidin with a cure rate of 100% and the same dose of vancomycin had only 67% survival. Furthermore, the intraperitoneal administration of Mersacidin eliminates nasal inoculated MRSA strains in the rhinitis model of mice. The evidence proves that although Mersacidin has higher MIC in vitro, the Mersacidin has good in vivo effect and has the potential of developing into antibacterial medicines.
Mersacidin was synthesized from a gene cluster AJ250862.2 consisting of multiple related genes including transcription, translation, transport and modification. The gene cluster is 12324bp long, consists of 10 ORFs, encodes a 68-residue propeptide from mrsA, which is decarboxylated and oxidized by mrsD to produce 2-thioethylamine function at the C-terminal cysteine. The modified mrsA is used as a substrate for producing a four-ring structure of mrsM, and is secreted into a final bioactive compound after mrsT processing. One of the regulatory genes mrsR1 is responsible for controlling the synthesis of mrsA; there is also a two-component system, mrsR2/mrsK2, encoding sensors and kinases involved in the induction of immune genes mrsE, mrsF and mrsG. Bacillus amyloliquefaciens FZB42 exogenous expression of Mersacidin by host bacteria has been successful, but the expression level is low. This demonstrates that exogenous expression of Mersacidin is possible, with the problem of how to increase the expression level, mainly how to increase the tolerance of the expression strain to Mersacidin.
Disclosure of Invention
In order to solve the problems, the invention utilizes high-fidelity enzyme to amplify the mrsK2R2FGE, mrAR 1D and mrMT of Mersacidin gene cluster genes mrsK2R2FGEAR1DMT, and utilizes Gibson cloning technology to connect the 3 segments of Mersacidin gene cluster genes to construct a Mersacidin expression cassette, the expression cassette is placed at the downstream of a strong promoter, and the expression cassette is introduced into genetic engineering bacteria Bacillus subtilis SCK to realize the efficient secretion expression of Mersacidin, thereby providing a cheap biological antibacterial agent and preservative for feed additives, veterinary drugs, foods and medicines.
It is an object of the present invention to provide a gene expression cassette for encoding secreted Mersacidin.
In order to achieve the above purpose, the present invention adopts the following technical scheme:
the gene expression cassette adopts a cloning amplification technology to obtain three cloning fragments: gene mrsK2R2FGE, gene mrsAR1D, and gene mrmt; the gene msK 2R2FGE is a fragment 1, and consists of a gene msK 2 encoded by an msK 2 protein, a gene msR 2 encoded by an msR 2 protein, a gene msF encoded by an msF protein, a gene msG encoded by an msG protein and a gene msE encoded by an msE protein, wherein the gene msAR 1D is a fragment 2, and consists of a gene msA encoded by a pro-peptide msA, a gene msR 1 encoded by an msR 1 protein and a gene msD encoded by an msD protein, and the gene msMT is a fragment 3, and consists of a gene msM encoded by an msM protein and a gene msT encoded by an msT protein.
Further, the three cloning fragments are respectively selected from a primer G1 cloning fragment 1 and a primer G2 cloning fragment 2, a primer G3 cloning fragment 2 and a primer G5 cloning fragment 3; the nucleotide sequence of the primer G1 is shown as SEQ ID NO.2, the nucleotide sequence of the primer G2 is shown as SEQ ID NO.3, the nucleotide sequence of the primer G3 is shown as SEQ ID NO.4, the nucleotide sequence of the primer G4 is shown as SEQ ID NO.5, the nucleotide sequence of the primer G5 is shown as SEQ ID NO.6, and the nucleotide sequence of the primer G6 is shown as SEQ ID NO. 7.
Further, the nucleotide sequence of the gene expression cassette is shown as SEQ ID NO. 1.
Further, the gene expression cassette is sequentially from the 5 'end to the 3' end: the genes mrK 2 encoded by the mrK 2 protein, the genes mrR 2 encoded by the mrR 2 protein, the genes mrF encoded by the mrF protein, the genes mrG encoded by the mrG protein, the genes mrE encoded by the mrE protein, the genes mrA encoded by the pro-peptide mrA, the genes mrR 1 encoded by the mrR 1 protein, the genes mrD encoded by the mrD protein, the genes mrM encoded by the mrM protein, and the genes mrT encoded by the mrST protein.
Further, the total sequence of the expression cassette genes is 12324bp:1 to 1440 are the genes mrsK2;1437 to 2159 gene mrsR2;2402 to 3313 gene mrsF;3310 to 4068 gene mrsG;4085 to 4819 gene mrsE;5104 to 5310 gene mrsA;5406 to 6047 gene mrsR1;6096 to 6680 gene mrsD;6892 to 10080 gene mrsM;10132 to 12324 gene mrsT.
Further, the gene expression cassette comprises a promoter, and the 3' -end of the promoter is connected with the pro-peptide coding gene mrsA.
The second object of the present invention is to provide a recombinant expression vector which can realize the expression of secreted Mersacidin.
In order to achieve the above purpose, the present invention adopts the following technical scheme:
the recombinant expression vector comprises the gene expression cassette.
Further, the recombinant expression vector is a plasmid vector or a viral vector.
Further, the viral vector is a lentiviral vector, an adeno-associated viral vector or an adenovirus vector.
Further, as a preferred embodiment, the plasmid vector is a pP43NMK vector.
Further, the recombinant expression vector includes, but is not limited to, a pP43NMK vector, other bacillus expression vectors with promoters and signal peptides, and vectors containing a secreted Mersacidin expression cassette "promoter-Mersacidin" can also be constructed.
The invention aims at providing a genetically engineered bacterium, which has higher expression level than wild bacterium after culture, and has low cost of fermentation medium, short fermentation period and easy industrialization.
In order to achieve the above purpose, the present invention adopts the following technical scheme:
the genetically engineered bacterium comprises the gene expression cassette or the recombinant expression vector.
Further, as a preferable example, the genetically engineered bacterium is Bacillus subtilis SCK.
Further, the medium composition of Bacillus subtilis SCK and 168 comprises: 10+/-5 g/L of soybean meal powder, 10+/-5 g/L of yeast powder, 10+/-5 g/L of peptone, 10+/-5 g/L of glucose and 5+/-2 g/L of sodium chloride.
Further, the genetically engineered bacteria include, but are not limited to, bacillus subtilis, and other genetically engineered bacteria such as bacillus licheniformis and bacillus pumilus can also realize transformation and expression of vectors.
The invention aims at providing a preparation method of secreted Mersacidin, which has low culture cost and high yield and provides a new direction and thought for realizing industrial production of Mersacidin.
In order to achieve the above purpose, the present invention adopts the following technical scheme:
the preparation method based on the secreted Mersacidin specifically comprises the following steps:
1) Constructing the recombinant expression vector;
2) Transferring the recombinant expression vector into the genetically engineered bacterium;
3) Screening positive recombinants, and fermenting and culturing in a culture medium.
Further, the preparation method of the secreted Mersacidin can further comprise the following steps:
4) Taking fermentation liquor to measure the antibacterial activity and content of the fermentation liquor;
5) Determining the antibacterial effect of the fermentation broth, and detecting antibacterial activity;
6) Filtering the fermentation liquor, and measuring the content thereof by a high performance liquid phase method.
The fifth object of the present invention is to obtain a secreted Mersacidin obtained by the above preparation method.
The invention has the advantages that:
1. the secreted Mersacidin obtained by the invention has a random structure, good activity, strong biological stability, good tolerance to heat, gastric juice, intestinal juice and the like, and remarkable antibacterial effect.
2. The Mersacidin expression cassette vector obtained by the invention is a promoter-mrsK 2R2FGE-mrsa 1D-mrmt gene, and realizes the synthesis and transportation of Mersacidin to extracellular secretion expression by combining Mersacidin gene cluster coding genes.
3. The invention discloses a preparation method of secreted Mersacidin, which has low culture cost and high yield and provides a new direction and thought for realizing industrial production of Mersacidin.
4. The invention uses Gibson cloning technology to connect the gene fragments of mrSK2R2FGE, mrAR 1D and mrMT to the expression vector with promoter to construct the Merdacidin expression cassette vector promoter-mrSK 2R2 FGE-mrAR 1D-mrMT gene. Because the carrier has mrsR1DMT which can process, modify and transport the propeptide, the synthesis and transport of Mersacidin to extracellular secretion expression are realized.
5. The invention converts a recombinant expression vector containing a Merdacidin expression cassette into genetically engineered bacteria to construct a strain. The strain is cultivated in a relevant culture medium, the activity of the strain is judged by measuring a bacteriostasis circle, and the expression quantity of Mersacidin in Bacillus subtilis is measured by adopting HPLC. The expression system has the advantages that the Mersacidin expression level is higher than that of wild bacteria, the cost of a fermentation medium is low, the fermentation period is short, and the industrialization is easy.
6. The invention ferments and expresses Mersacidin by genetic engineering and fermentation engineering for the first time, uses a safe strain Bacillus subtilis SCK168 as an expression host bacterium, uses a pP43NMK expression vector with a promoter P43, carries out recombination on a Mersacidin gene cluster AJ250862.2, and constructs an expression vector by using an expression cassette Mersacidin and the pP43 NMK. The Mersacidin expressed by the invention has high activity, improves the secretion expression level of Mersacidin in Bacillus subtilis, and is favorable for application and popularization.
7. The expression level of the secreted Mersacidin produced by the preparation method disclosed by the invention is up to 1.26g/L, and is higher than that of Mersacidin in all the current reports.
Drawings
FIG. 1 is a diagram of a recombinant expression vector construction process;
FIG. 2 shows the bacteriostatic activity of the broth against Clostridium perfringens (A: bacillus subtilis SCK: 168 broth supernatant; B: bacillus subtilis MRS: 08 broth supernatant; C: bacillus subtilis MRS: 24 broth supernatant; D:100ng vancomycin);
FIG. 3 shows the high performance liquid spectra of Mersacidin pure (A) and broth (B).
Detailed Description
The technical scheme of the present invention will be further clearly and completely described in connection with specific embodiments. It will be apparent that the described embodiments are only some, but not all, embodiments of the invention. Therefore, all other embodiments obtained by those skilled in the art without undue burden are within the scope of the invention based on the embodiments of the present invention.
EXAMPLE 1 construction of recombinant vector
1) The vector pP43NMK (BioVector NTCC inc.) was double digested with HindIII and PstI.
The enzyme digestion reaction system is as follows: 10. Mu.L 10X FastDigest buffer, 10. Mu.L vector (100 ng/. Mu.L), 5. Mu.L HindIII and 5. Mu.L PstI, ddH 2 After mixing 70. Mu.L of O, the linearized carrier is recovered from the digested product in a water bath at 37℃for 60 min.
2) Using Bacillus HIL Y-8554728 genome as template, the mrsK2R2FGE, mrsAR1D and mrsMT gene fragments were amplified using G1/G2, G3/G4 and G5/G6 as primers, respectively. Primers G1 and G6 have homologous sequences to the vector, and G2 and G3, and G4 and G5 also have homologous sequences (as shown in FIG. 1, regions of the same color are homologous sequences).
The amplification system was 50 μl: 2.5U/. Mu.L of high-fidelity enzyme, 1. Mu.L; 2 Xreaction buffer, 25. Mu.L; primers, 1 μl each; template, 1 μl; ddH 2 O, 21. Mu.L; the amplification conditions were: denaturation, 98 ℃,0.5min; annealing at 55 ℃ for 0.5min; extension at 68℃for 1.5min for fragment 1, 3min for fragment 2 and 2min for fragment 3.
3) The three fragments are mixed with a linearization pP43NMK vector and then connected by adopting a recombinant cloning kit method.
The reaction system is as follows: mu.L of 2 XGibson mixture, 1. Mu.L of linearized vector (50 ng/. Mu.L), 0.9. Mu.L of recovered and purified DNA fragment 1 (50 ng/. Mu.L), 1.8. Mu.L of recovered and purified DNA fragment 2 (50 ng/. Mu.L), 1.3. Mu.L of recovered and purified DNA fragment 3 (50 ng/. Mu.L), were mixed, placed in a water bath at 25℃for 30min and an ice bath at 0℃for 15min, and the reaction product was transferred into E.coli competent DH 5. Alpha. To screen positive recombinants (kanamycin resistance), thus constructing vector pP43NMK-mersacidin (FIG. 1).
The total gene sequence of the expression cassette is 12324bp:1 to 1440 are the genes mrsK2;1437 to 2159 gene mrsR2;2402 to 3313 gene mrsF;3310 to 4068 gene mrsG;4085 to 4819 gene mrsE;5104 to 5310 gene mrsA;5406 to 6047 gene mrsR1;6096 to 6680 gene mrsD;6892 to 10080 gene mrsM;10132 to 12324 gene mrsT.
Such vectors include, but are not limited to, pP43NMK, other Bacillus expression vectors with promoters and signal peptides, and vectors containing the Mersacidin expression cassette "promoter-Mersacidin" may also be constructed.
EXAMPLE 2 transformation of recombinant vectors
The vector pP43NMK-mersacidin was transferred to Bacillus subtilis SCK168 by electrotransformation under the following conditions: c=50 μf; pc=200 ohm; v=1.0 kV. Positive recombinants were screened and designated MRS08 and MRS24.
The host bacteria include, but are not limited to Bacillus subtilis, other genetically engineered bacteria such as bacillus licheniformis and bacillus pumilus, and transformation and expression of vectors can be realized.
Example 3 detection of bacteriostatic Activity of fermentation supernatant on Staphylococcus aureus
After the MRS08 and MRS24 strains obtained by screening were cultured for 16-22 hours under the conditions of 37 ℃ and 200rpm/min of culture medium (10 g/L of soybean meal powder, 10g/L of yeast powder, 10g/L of peptone, 10g/L of glucose and 5g/L of sodium chloride), the bacteriostatic activity of the fermentation supernatant on clostridium perfringens was measured in different time periods.
The antibacterial activity is measured by the following method:
1) Bacterial recovery: clostridium perfringens ATCC13124 plates were streaked and incubated at 37℃for 20h; single colonies are picked up and cultured in a corresponding liquid culture medium at 37 ℃ and 200rpm/min for about 12-16 hours. Diluting the bacterial solution to OD with physiological saline 600 Absorbance of 0.1 (about 10 8 CFU/mL), ready for use;
2) Taking 10mL of fermentation liquor sample 8000g, centrifuging at 4 ℃, and collecting supernatant for preservation at-20 ℃ for later use;
3) In an ultra-clean workbench, 100 mu L of indicator bacteria liquid is absorbed and added into 100mL of corresponding agar culture medium with constant temperature of 50+/-5 ℃ to be gently shaken to avoid foaming, and the content of bacteria in the culture medium is 10 6 CFU/mL; pour 15-20mL into each accompanying dish, spread evenly, and let it cool and solidify. Uniformly punching by using a sterile puncher, sucking 150-200 mu L of fermentation liquor sample, injecting into the corresponding hole, setting Bacillus subtilis SCK fermentation liquor as negative control, vancomycin (1 mu g/mL) as positive control, marking on a culture dish, and placing the culture dish in a refrigerator at 2-8 ℃ for 1-2h for sample diffusion. The dishes were transferred to a 37℃incubator for cultivation.
The growth condition and the antibacterial effect of the thalli are observed in the following 6-12h, the antibacterial circle can be observed in 8-12h generally, the diameter of the antibacterial circle of the strain fermentation liquor of Bacillus subtilis MRS (figure 2B) and Bacillus subtilis MRS (figure 2C) is equivalent to that of vancomycin (figure 2D), and the antibacterial effect is strong.
Example 4 determination of stability of Mersacidin in fermentation broth
1) Respectively taking 5mL of fermentation liquor supernatant, and regulating the pH value of the supernatant to 2.0, 7.3 and 12.0 by using 5mol/L HCl or 5mol/L NaOH, and carrying out water bath at 37 ℃ for 3 hours;
2) Taking 5mL of fermentation broth supernatant, and treating at 100 ℃ for 1 hour; adding 0.2mL trypsin and proteinase K solution into 1.5mL fermentation supernatant with pH value adjusted to 7.3 respectively to make the final concentration of enzyme be l mg/mL, carrying out water bath at 37 ℃ for 4 hours, and carrying out boiling water bath treatment on the reaction system of the control group and all enzymes for 5 minutes to inactivate the enzyme;
3) The antibacterial activity of the treated fermentation broth against clostridium perfringens was tested according to the test procedure of example 3; mersacidin was found to be resistant to acid and base, pancreatin and proteinase K, and not durable in high temperature tolerance (table 2).
TABLE 2 stability of the antibacterial Activity of fermentation broths against Clostridium perfringens
O: 1.25 times dilution of distilled water, 5000rpm/min, centrifuging for 10 min;
a: diluting the centrifugal supernatant with distilled water by 1.25 times, and adjusting the pH to 7.3;
t: diluting the centrifugal supernatant with distilled water by 1.25 times, adjusting the pH to 7.3, and heating at 80 ℃ for 2h;
2: pepsin blank control;
7.3: trypsin, proteinase K, catalase blank;
p: pepsin treatment;
tr: trypsin treatment;
k: proteinase K treatment;
h: and (5) catalase treatment.
Example 5 determination of Merdacidin content in fermentation broth
Culturing the MRS08 strain and MRS24 strain obtained by screening under the conditions of 37 ℃ and 200rpm/min of culture medium (10 g/L of soybean meal powder, 10g/L of yeast powder, 10g/L of peptone, 10g/L of glucose and 5g/L of sodium chloride), and measuring the content of Mersacidin in fermentation supernatant in different time periods; the method comprises the following steps:
the method is characterized in that Mersacidin (99% of Nanjing Jinsri) synthesized by biological company is used as a standard, and high performance liquid chromatography is adopted for detection, wherein the chromatographic conditions are as follows:
reversed phase chromatographic column: c18 (4.6X1250 mm or 150 mm);
eluent: mobile phase a (0.1% trifluoroacetic acid), mobile phase B (90% acetonitrile);
column temperature: 25 ℃ (or room temperature);
detection wavelength: 260nm;
maximum pressure: 200bar;
gradient elution was performed as in table 3:
TABLE 3 gradient elution procedure for mobile phases
By adopting the detection method, the highest content of the active ingredients is 1.26g/L.
The pure product is dissolved in water, the peak time of the pure product is measured by loading, and then the fermentation liquor is loaded.
The external standard method is calculated in proportion to the peak area and the concentration (consistent loading amount), and the content is calculated by adopting the following formula:
wherein AX is the peak area of the fermentation broth Mersacidin; CX is the content of Mersacidin in the fermentation broth (μg/g); AR is peak area of control: CR is the concentration of control (. Mu.g/mL). The pure product and fermentation broth patterns are respectively shown in fig. 3A and 3B.
Sequence listing
<110> Chongqing City academy of livestock sciences
<120> Gene expression cassette for encoding secreted Mersacidin and method for preparing the same
<130> 2022.1.14
<141> 2022-02-24
<160> 7
<170> SIPOSequenceListing 1.0
<210> 1
<211> 12324
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 1
ctaattgaca ttgttatact tagatggcgg actcggaaag gtaattttaa atcttgtgcc 60
aattcccggc tgactatata tatcaatatt tcccccatgt gccttgataa tttgttgagc 120
aatagccatt cctaatccag tccctgagtt atttgacgta gcgcttgtcc ctctgaaata 180
ccgatcaaat aaacattcga ccgtctcttc gtccattcct atcccatcgt cttctattat 240
aatttgtatt tcattgtcat gtaacacgtc ctgatataat atgaccttta ttttagtgcc 300
cggaggatta tgtttaatac aattagcaat caagttttca actgcacgct ttaggtacct 360
ttcatccata ttaaaaagta tcttattgtg actggattct aaagcgaatc tcttattttc 420
tgactccggt agcagcttca ttttttctaa agtgtcatga attactttca ctacgttttt 480
ttcttcaaga tggattggaa gcgactcatt tttcaattga aaagttaagt tgaaatcttc 540
aatcagcttt tccatatatt cgacacgttc ttccattatt aaggaaaaat cacgcacttg 600
ctgattttcc cactcatatt catttgaaga taaaagaacc gtatatccct taataaccga 660
aagaggggtt tttaaatcat gtgagacacc ggccatccac tcttctcgtg tcttttccaa 720
taattctcgc tcagccttat tcctttgaag cgttgaggta agttcagaca gagcctgcat 780
taattcttga taggtcttat atccagattt attatgtcta tatttgcttg aatgaaactt 840
ccaatcataa ggttcttcat atttttcttt agacaaattc tcaatccaag atacaataaa 900
cagcagggga gcacctagtt tttttccgta aaatattgca atgacaatcc ctgccataat 960
aatagaaaca atccacaagt tattcaccca atagaaaaaa gggttatttt tttccatcgg 1020
ctttcccaat acccatgtta aatcctgatt gtttttcgtt tcataccacg tagataattg 1080
ataacctttt ttggcaggat acatgtaatc tgatattaac tctccaagaa tataatgctt 1140
aggtatattt tgaggtttat taaaagaaaa aacctcatct ccttgttcat ctaaaatttg 1200
aatccacatc cggttctcta ataaatcttc ttttgctttc gtatttattg aaaattgttt 1260
atctgcaaca actgtttggt caacaatttt ttttaaggat aagtgcggcg tttccatttt 1320
attctgacct aagacgaggc tgaaaaatat gatactgccc acaatgagca caccccaaat 1380
aaacatgagt aaaaaaagtc tcgatacgaa gtaaaatgct atcctatttc tcagcttcaa 1440
aataaatcct catctatagg ctctgcttca aatatatagc cctgtcctcg aaccgtttta 1500
atccatctag gtctgctcgg gtcttcctct aatttttcac gtaatcgtct tacatgtacc 1560
attacagtac tatctccgcc ataaaactcc ccccacacat ctttataaat ttggtgttta 1620
cttaaaattt gattgggatg ttcacagaaa taaatcagaa gtttcatttc ctgagcaggg 1680
caatctattc ttgtcccgtt aacaacaagt cttccggtat tgggatctat tttaaaatat 1740
tcataatcgt atacctgttt tagagggtaa gaagaagaga gttgagtcgt tctctttaat 1800
tgggctttta cacgagctac aatttctagt ggattaaatg gtttagtaat atagtcatct 1860
cccccaaaac taaacccttg caatttatct aaatctgttg tttttgccgt taagaagagt 1920
atcggcacat ttgtatgcga gcgtattttg ctgcataagg tgaagccatc agtgtccgga 1980
agcatgacat ctaataaaat aatatttgga agttcctgat cgattttcag aagggtttcg 2040
ctccctgtca tagctgtgga aatattgctg aaaccttcct tttcaaagca agttattaat 2100
aagtttaaga tatgttcgtc atcatccacc atgaggattt tgttctcttc taacgtcata 2160
agttaccctc ctttttattt cttattttat atgagatcaa tgacataaag gtcagaaaag 2220
gaaagaattt aactttcgtt aagggttcag aatattcttt cgaattttta accttgatat 2280
tcaggtatca atataactac atacagaaaa taaaccaggg atgtcgttaa gtgaatgttt 2340
aggaagagtt tcgtttgtgt ttaaagaaca tcgcttatga taaaagtgag gtgagagaca 2400
aatgaatgat caaatagtgg taacacacga tctgactaaa aagtataaaa agcatacttc 2460
tgttgatgga ttaaacttaa ggattaggcg tggcgaaatt tatggttttc ttggaccgaa 2520
tggtgctggt aaaacaacaa ccatccgaat gttattaggt ttaattaaac caacaaaagg 2580
aaacatcgaa atctttggcc aaaacctaaa caagaatcgt ttgcagatat tgcaaagaat 2640
cgggtcactg gtagaatctc caacttatta tggtaattta acaggttacg aaaacttaga 2700
agctgttagg aggttacgag gacttccgga acaacaggtc aatgaagtat tggaaactgt 2760
aaggttatct aaagtagcaa atcgactgac taaggagtat tcccttggaa tgaaacaacg 2820
tttgggaatt gcagttgccc tgttaagcag tcctgattta ttaattctgg atgaaccgac 2880
aaatggttta gatccatccg gtatccaaga aataagagag ctaattaaag aattgcctaa 2940
atcgggaatg agtgttattg tatccagcca cttattgagt gaaatagatc aaatggctac 3000
tcaagtggga attatcaaca atggaaaaat gatttttcag gactcgattg caagtttaca 3060
tcaaaaaaga aaaccactat taaaagtcgg tgttagtgac gtaatcgaag caaaaacaat 3120
attaaacagg aaaggattaa aggttgattt acaaaaaaat tatttgtggc tgtctcaaac 3180
agaaccggaa ttcgtttcag aaatcaattc catacttctt cattcagggc tgtctgtatt 3240
tcgacttgaa gaaaagacac gatcacttga ggatattttt ttagaattaa ccggtacaga 3300
gggaagtcta tgaaaaagtt attatgggca gatcaattaa aactgaaacg ttcgtcgtta 3360
ttgattgtag tcttattggt tcccttactc attatagcat atgagttggt aaatcttact 3420
tatcgatctg aatacgtgga aaaacaagct gaaatgttcc atgctggatc aatgtggatg 3480
tatttactgt atgataacag tttgttattt ggtctgggtt ttccattagc cgccacactt 3540
tctgcgtcaa taatagcaaa tatagagcat caagcaaacg gatggaagca aaccctttct 3600
tttcctgtat ctagaatgcg aatttatgta agtaaattta tttgcttagt agtcagttta 3660
tttatttcgt caacaatctt cttgctcggc atggtactgc tgggcaaact ggtaggattc 3720
gaaggtagtg taccttgggg acttttgttt ggagatagtt acagcatgtt agttacagta 3780
ctgcctataa tggcattcca gatatggtta tctatggtgt ttagcaacca agcattctca 3840
attcttgtag gatcagtatc atctataatg ggtttgtttt tggcagctgc tcaatcaacg 3900
agatggtttc cgctggctta tcctagtcaa tcttcgacag tcattctgca gtatgaaggt 3960
ataggatata acccagatct ttcatcttac ctttgcatta gccttttctt agggataatt 4020
atattatttc taggctctat tcattttgct aaacgggatg ctttgtaaaa aggaggcgaa 4080
atacttgaaa aacattttat ttgtagaacg tttaaagctt aagcgatcaa agttatggat 4140
catctactta ttagggcctt tgttaggtgt atccctggca tacactaact ttattaaaaa 4200
ctataacctt tttatgaatc ccggagacaa tccctgggta gaggcttgga cacaagttgc 4260
cttatttatg ggcccttttg tattgcctat cgtagtggga attttcgccg cccttgtttg 4320
caggggggaa catgtaggag gcggttggaa acagcttcta gccttaccag tcaaacactc 4380
agatatcttt ctgggaaagt ttctaacagt ggtccgcatg atattcatta gtatgtccat 4440
tttaatcctc ttatttattg gattcggtta tatgttaggc ataagcggga gtcttccttt 4500
acttacaatt ctaggttatg gaattagagg gatcttagct tgtttaccat taattttatt 4560
gcagcttatt gtttcaatca ggtctaaaac atttggcata ccactcgctg ttagcattgt 4620
ttttacatta ccggccatta ttattgccag tacaccatta ggtcaagtat atccatggac 4680
acagcctatg ttagcaatgt cacccgaaga tgaatcaccg attcaatcaa atttcctgtt 4740
ttactcaatt atggtaataa cgtgtctcgg tctcctggtt tacggaataa gaagttttac 4800
taaacgagac cttacgtagg gtatatgcgg tataaactta tgagaattcg agacaaggta 4860
aactaatttg actagcgcta tgtaaaacag aaatttatat gaaggtaaga ctaaatcttt 4920
ttggttgtat tctttgaaac taaacgacta atggaaaagg tgatgtttca aagcataaga 4980
cataagaaat ataaagatat cttaagactc tttatttaaa cattttttac atttaataat 5040
atctcttcca tttttttgat tatgagttaa tataatacta tacttaataa gggggtgaat 5100
acaatgagtc aagaagctat cattcgttca tggaaagatc ctttttcccg tgaaaattct 5160
acacaaaatc cagctggtaa cccattcagt gagctgaaag aagcacaaat ggataagtta 5220
gtaggtgcgg gagacatgga agcagcatgt acttttacat tgcctggtgg cggcggtgtt 5280
tgtactctaa cttctgaatg tatttgttaa tttgatttat ataggctgtt tcccttcaga 5340
aggaacagcc tatattttat tatataaact attagaaaat tcttaaaaaa caggagggta 5400
aatcattggg gaaaactctc gtttgttcag aaaatagcta tttccaagca tatatgaatc 5460
atttattaac gccagatagt aatgaaataa taaatgttaa cacattggat gaactaaaac 5520
aaataatatc caaagaaaat ttttcctctg taatcatcga tacttgccac cctaatgact 5580
tagtgttgca actgataaaa tcgatatctt gcccagtcat aatacttaac tccttagaaa 5640
ctaacgtttc agattataac cctggtccaa tattaaatca aataaataat gtttcaaccc 5700
taaaacataa tgtttttcaa ttgtctttca caactttttt cgacgttgga aagcattgta 5760
tttggaaaaa gaatgaatat atccctctag caatacaaga atttaaaatt ttatatttgc 5820
tttatttaaa ttcaaataaa atagtctgtt ctgaagaact tattgaatat gctgacctta 5880
ctggtaggtc aagtctttat gtacacatta gttctcttag agaaaaagta gaggataacc 5940
ctggagatcc aaagattctt caaacaaagt ttggaaaagg gtacctctta tctgacagta 6000
catatatttg tcttgaaaaa aaagcagact caaaaaatgt cgtgtaaaaa ggatgaccca 6060
aaaatcattt taaaatgact tttgagtcat cccatttatg ttagtgaggg gtgttttgtt 6120
ctttctttaa aacctttttc tattgctaat aaagctttgt cgggtgtaat tagaccacga 6180
ttaggttttc ttgtacccgt cgcaatctca aacgccataa tttcaactgg ttcaataaca 6240
atatgcccat cttttcttaa ttgttcaata ttcctggaaa caactgtttt attccacatt 6300
aaatcgttca tattaggaaa gaaaatagtg ttatgtggat gagctaatac agtagttgca 6360
actaaattca ttgctacacc attagcagtt tgtcctaaga tgttcgctgt agctggaata 6420
atgcaatata tgtccgccca gcggccaatt tctacgtggc tatgtctttt tccgttttcc 6480
ccatgttctg agtatacatg gtcacaaaaa taagaaacag tatgagctgg aataaggtct 6540
tccgctgttt ttgtcataac aacccttatt tccttaaaga agcttttaaa atataagaga 6600
tacgaggaga tgccgacaga tgagattgat ccgcaaatcc cgatcaataa ctttttatct 6660
tttaatattg aaatactcat ttttttctcc ctctgtaaat tttaaacaat catactacac 6720
aattattctt tttgtggtgt ttattccaaa tattaaatat tcttaataaa cacatataaa 6780
ataaacctaa acttctttta aaattctttt aacttttaaa tggctctgct atatttatgg 6840
ataattaagg aatattaatt gttcaaattt attaaaaatg aggtgttcaa tatgcataca 6900
aaattcaaac ggaattcggt atggaatagg tcttcttcga taagtgaaag aaaagtaagg 6960
cgttcactta atactaattg ggatgaacta acaaacagac gcttcgaaag atggaaaagc 7020
cttgttgaaa gtgatgaggg gattcgaatt gaggatgtat tagccaccca aaatattgac 7080
gaagaaaccc taaagcatac tatcaatgca aaagaagtgg aatttattaa tgaaggtgat 7140
catcaaggat ggcttgaaat tattcagcta gttgatgaac aatcctataa aaatgtaaat 7200
atagaagtta gaaaagatat tctcttcttt agttttataa aaccattttt gaaaatagca 7260
agaggcaaat tagaggaagt attatattct cactctacta aatctctgat aaaggaagaa 7320
cttagtccgt cggtaattga tgatttactt aataatcttg gtgaaacttt atcagctata 7380
agtagtcgga tattaatatt ggagttaaat gtagcaaggg tatcaggaaa gctgcggggt 7440
gaaacttctg aagaacgagc ctcttatttc aatcaagccc ttttaaatga cccggcatat 7500
gttcgatcaa ttcgagaaga atacatagtt ttaacaaggc tgttagcaac aaaaacaatg 7560
tattggattc aaaatacttc tgatctcctt gtaagatttc atcaggataa agggatatta 7620
gaatctgagt ttagtaatgg tcaaaaatta gggaaaatta tttccatcga tacaggaagt 7680
ggcgtctcag atactcataa caaaggaaaa acagtcgcca ttttaaactt tgaaactgga 7740
attaaaattg tgtataagcc tcgttcatta gaaatagacg taaaatttaa taaatttgta 7800
aattatctaa atggtaaaaa tttaagtttt gacttaaaaa ctgtacacac acttaacaaa 7860
aaatcttatg gatggacgca gtttatctct tataaagaat gtcaggaaga actgcaaatt 7920
ggaaagtttt attggcgtat tggaagttat ttggctatct tatatgcaat gaatgcggta 7980
gattttcata tgcaaaattt aattgctgat ggagaatatc ctattttagt tgatttagaa 8040
tctttatttc ataataattc tacgtataca gataccagtg cttttagtcg cgcacaagaa 8100
catattgaac ggtcagtttt acgaattggg ttattaccga gaaaaataaa tagtaaagct 8160
ggatttgaag gaattgacct tagtgcatta ggtgcacaag aaggacaagt atctccgcat 8220
aaaaccagta caatagttga tcgagataaa gatacagtca ggatagaaga aaaaaacttt 8280
ccaattccag ttagtcagca tagacctatg ctgcatggac aaatcattaa tactgttgct 8340
tacgaaggaa atattataaa aggatttgaa gaaacctact tccttttcat gaaatataaa 8400
caagacatgc tcgaacaaat agattctttt aaaggggtta ctgtaagaca aatattgcgt 8460
ggtacatctc gctatgcaaa ccttctgaaa ataagtttac atccagattt catgagagac 8520
ggcttagatc gtgaaatgat tttagataaa ttgtggctag atacaaaatt gaatccacga 8580
ttgaaccaag ttgtaaatag tgaaaaggaa ggcttattcc ttggggatat cccatatttc 8640
acaagcaagc ctgaatctac aaatatgtgg gattccagcg gtcgaaaaat caacaatttt 8700
tttaaaacaa gtgccttaaa tgagacaaag gaaaaaataa atgaaatgaa tgaaagtgac 8760
tgtcatgaac aagtaagctt tataaaaaca gctattttag taattaagga ttcttatcgt 8820
aaacataaag tatttgatat aaatcctcga ttacacgttt ttaacccaaa agattttttt 8880
caagaagcta ttaaaatcgg agactttctt gctagtaggg cgattgaagg tgaacagtta 8940
gatggacaag aggatgtatc ttggatcgga tcgtttgttg acaatcaacg agaggatcaa 9000
ttcaagattt cagctgcaaa tagttcatta tacgagggtg taggtggtat ttctctcttc 9060
cttgcttatt taggtcgcct ctctaacaat gaaaaataca ccaaactatc taaaaaagct 9120
ttagtggcag tacacaaaaa tatgtctgca tctagtgatt taggtgcctt tgggggaatt 9180
gcttcttacc tttatttgtt ggatcattta tcaaaattat ggaatgatga acaactattg 9240
aaaaacgaac tttattctgc cctcaacaaa ttagattctt tgatcgaaag ggatgaaaac 9300
aacgatattt taacaggggt ggctgggaca gcagttattt taataaattt gtttaaacgg 9360
tataaagaag aacaaatctt aaacttgatt acaaaatgcg gaaatcgtct tattcaaaat 9420
ataaacgtta tggaaaaggg agttggatgg aaagtcccgg caaacccaac gccagcctcc 9480
ggatttgctc atggtgcctc aggaattata tgggctcttt atgagattta cgcaattact 9540
aagcaaactg tatttaaaga ggtagctgaa aaagcgttag aatttgaaag aactttgttt 9600
attccggaaa aaaacaattg ggcagatatt aaacttgaaa acggacagtt tcgaaatgat 9660
aattttgttg cttggtgtaa tggcgcagca ggcataggat taagtaggat attgatcctg 9720
ccacacaatc aaaatgaatt gataaaagat gaagcacatg tcgcaattaa tacaacccta 9780
aaatatggtt ttgaacatga tcaatcttta tgccatggtg atttaggtaa tctggacatc 9840
cttatgtacg cagcggaaaa ctttaataaa aagttaagcg taaatgtaac agaactaagc 9900
cataaaattt taaatgatat aaagctcaga ggatggttaa ctggatttga aaaaaataac 9960
gaatccccat ccttaatgat ggggtatgca ggtataggac ttggattgct taagattttt 10020
gcaccagtcg aagtgccatc agttttgaga ctccaatcac ctttagaact aaaattgtaa 10080
aattaaaatg agccttactt tgttaaggct ctatttctta gaggtgatcc aatgagaaga 10140
agagttcctc tagtaaggca aatgggacaa tatgagtgtg ggcccgcctg tctcaccatg 10200
attttaagtt attatgggag tactatatct ctaaataaaa taagtgaaca atgtgatgcc 10260
caaagaaatg gcgtatctgt atccatttta aaatcagtat cagaatatta tgggcttaac 10320
tgcaaagtat accaagtttc gtttaaagat ttgaaaaaat atatcaattc atatcttccc 10380
tgcatcatat tttgggatga acggcacttt gtggttttag aacagattaa aaaaggtctt 10440
tttcatataa ttgaccccaa cagaggaaaa ttgaaattat ccgaagaaga atttaaaaga 10500
cattatagca aggtaatctt gacttttaag aagtcagata aatttaaaga gatgatgcca 10560
tcacccgcag caaagtatta tttacgttat atagttaaaa gccgtactat tgtttcactt 10620
atcattctct tttcactgat cacacaagta gtcttcttag ccgttccttt tttaattaaa 10680
tatttagtgg atcattcttt aataagtaaa tcaacaaatt cttttctatt tttaggaatt 10740
gtagtcatca tagcagtttt tatattggga cttgttatgt ttatccgcaa ttatttcaca 10800
attaaacttc aagctattat aagtaaaagc atctcaaacg attttgtgga acatttatta 10860
aaattacctc tcaattttta tgaaaatcga acaaccggtg atattgcaat gagagtaagt 10920
aacatttcca tgataaggga gattatagct aagaatggag caacaatagt actagatatt 10980
attactttga tttcattttt tattgctatg ttaactcaat catttaaact tgcatttttt 11040
gctattggat tggcaattat tcaattctta ctaatgatga ttttgattcc aagaataaaa 11100
aatttaatcc ataatgactt atcaattcaa acaaccacac aaagtttttt agtggaagct 11160
ctaagagcta tcacttttat taaatcaaat ggtttagatc attctatcct aacaaagtgg 11220
tcaaattact atgataaaca aatcgaagca ttttcacagc gataccactt agacgctata 11280
atggatagca taagtgtaag catccgatat tgtgcacccc ttctcttatt atggtttgga 11340
tcaaaagaag ttatcaccgg aaatttaaca ctcggaggct tattagggtt tagcagctta 11400
ggaacatctt tcttgttgcc gattgcttct ttaataacag gcatgcaaca atttcaattg 11460
gtcggtgaca cttttgaacg aatgcaagat gttatggaaa ctgagcccga acaaatcaac 11520
caaacttcaa taattgaaac tgaactatca aaacaagata taaaacttga aaatgtcaca 11580
tttacacatc atagcttaca tattcttaaa gaagtttcat taaacattaa gtcaggtact 11640
aaattagctc tcgtaggccg tacaggtagt ggaaagacaa ctttatcaag aattatactg 11700
gggttataca aacccactaa gggaaaagta ttttatggtg aacaggactt gaagaattta 11760
aacctttacg agctccgaaa acaaatgggg gtcgtattac aagaaagctt tcttttcaat 11820
gatactattg caaacaatat agctggattt aaaagcttat ctcaggataa aattgaacaa 11880
gcagcaaaga gagtgcagtt acatgaagat ataataagaa tgccaatggg atataacaca 11940
attatcgggg aaaatggcag tatgttatca ggagggcagc gtcagcgcat agcaatagca 12000
agagctatcg tcgataaccc ttctgtagtc attttagatg aaataacaag taacttggat 12060
acattaacag agcatgaaat tgacgaatac tttgcaaaat caaatattac ccgtattgta 12120
ataactcatc gtcttttaag tagccaagac tctgatttaa tagtggtatt agatcaagga 12180
aaaatagtcg aaaaaggaaa acatcaagag ttattagaga aaaagggata ctattataac 12240
ttatggataa aacaagtagg ggatagacag aaagctacgc tgcaaaagcc ctttttcctc 12300
aatgagcaaa ctggcaaaac ttga 12324
<210> 2
<211> 48
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 2
taacacatgc ctcagctgcc taattgacat tgttatactt agatggcg 48
<210> 3
<211> 40
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 3
taagtttata ccgcatatac cctacgtaag gtctcgttta 40
<210> 4
<211> 40
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 4
ggtatatgcg gtataaactt atgagaattc gagacaaggt 40
<210> 5
<211> 40
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 5
atttacagag ggagaaaaaa atgagtattt caatattaaa 40
<210> 6
<211> 40
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 6
ttttttctcc ctctgtaaat tttaaacaat catactacac 40
<210> 7
<211> 43
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 7
tctaaccgca ttagtaccag ttcaagtttt gccagtttgc tca 43

Claims (4)

1. The preparation method of the secreted Mersacidin is characterized by comprising the following steps of:
1) Constructing a recombinant expression vector containing a gene expression cassette with a nucleotide sequence shown as SEQ ID NO. 1;
2) Transferring the recombinant expression vector obtained in the step 1) into genetically engineered bacteria; the genetically engineered bacterium isBacillus subtilis SCK168;
3) Screening positive recombinants, and fermenting and culturing in a culture medium to obtain the secreted Mersacidin;
in step 1), the vector is a pP43NMK vector.
2. The method of claim 1, wherein the gene expression cassette employs a clonal amplification technique to obtain three cloned fragments: gene mrsK2R2FGE, gene mrsAR1D, and gene mrmt; the gene mrK 2R2FGE is a fragment 1, and consists of a gene mrK 2 encoded by an mrK 2 protein, a gene mrR 2 encoded by an mrR 2 protein, a gene mrSF encoded by an mrF protein, a gene mrG encoded by an mrG protein and a gene mrE encoded by an mrE protein; the gene mrsAR1D is a fragment 2, and consists of a gene mrsA encoded by a propeptide mrsA, a gene mrsR1 encoded by an mrsR1 protein and a gene mrsD encoded by an mrsD protein; the gene mrsMT is a fragment 3, and consists of a gene mrsM encoded by an mrsM protein and a gene mrsT encoded by an mrsT protein.
3. The preparation method of claim 2, wherein the three cloning fragments are selected from the group consisting of a primer G1 and a primer G2 cloning fragment 1, a primer G3 and a primer G4 cloning fragment 2, and a primer G5 and a primer G6 cloning fragment 3; the nucleotide sequence of the primer G1 is shown as SEQ ID NO.2, the nucleotide sequence of the primer G2 is shown as SEQ ID NO.3, the nucleotide sequence of the primer G3 is shown as SEQ ID NO.4, the nucleotide sequence of the primer G4 is shown as SEQ ID NO.5, the nucleotide sequence of the primer G5 is shown as SEQ ID NO.6, and the nucleotide sequence of the primer G6 is shown as SEQ ID NO. 7.
4. The method of claim 1, wherein the medium composition comprises: 10+/-5 g/L of soybean meal powder, 10+/-5 g/L of yeast powder, 10+/-5 g/L of peptone, 10+/-5 g/L of glucose and 5+/-2 g/L of sodium chloride.
CN202210173000.6A 2022-02-24 2022-02-24 Gene expression cassette for encoding secreted Mersacidin and preparation method thereof Active CN114457102B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210173000.6A CN114457102B (en) 2022-02-24 2022-02-24 Gene expression cassette for encoding secreted Mersacidin and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210173000.6A CN114457102B (en) 2022-02-24 2022-02-24 Gene expression cassette for encoding secreted Mersacidin and preparation method thereof

Publications (2)

Publication Number Publication Date
CN114457102A CN114457102A (en) 2022-05-10
CN114457102B true CN114457102B (en) 2023-12-26

Family

ID=81415670

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210173000.6A Active CN114457102B (en) 2022-02-24 2022-02-24 Gene expression cassette for encoding secreted Mersacidin and preparation method thereof

Country Status (1)

Country Link
CN (1) CN114457102B (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5667991A (en) * 1994-09-12 1997-09-16 Hoechst Aktiengesellschaft Recombinant mersacidin and a method for production
WO2007036706A1 (en) * 2005-09-27 2007-04-05 Novacta Biosystems Limited Variants of the lantibiotic mersacidin and their use
CN110845586A (en) * 2019-11-21 2020-02-28 重庆市畜牧科学院 Secretory type grignard cyclic peptide and preparation method thereof
CN113354718A (en) * 2021-06-21 2021-09-07 重庆市畜牧科学院 Piranin precursor, expression cassette and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7785825B2 (en) * 2004-01-12 2010-08-31 The Board Of Trustees Of The University Of Illinois Compositions and methods for dehydration and cyclization of peptides, synthetic compounds, and lantibiotics
US7592308B2 (en) * 2004-03-26 2009-09-22 Novacta Biosystems Limited F3W variants of the lantibiotic mersacidin and its use

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5667991A (en) * 1994-09-12 1997-09-16 Hoechst Aktiengesellschaft Recombinant mersacidin and a method for production
WO2007036706A1 (en) * 2005-09-27 2007-04-05 Novacta Biosystems Limited Variants of the lantibiotic mersacidin and their use
CN110845586A (en) * 2019-11-21 2020-02-28 重庆市畜牧科学院 Secretory type grignard cyclic peptide and preparation method thereof
CN113354718A (en) * 2021-06-21 2021-09-07 重庆市畜牧科学院 Piranin precursor, expression cassette and preparation method thereof

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
Bacillus sp. HIL-Y85/54728 mersacidin biosynthesis gene cluster (mrsK2, mrsR2, mrsF, mrsG, mrsE, mrsA, mrsR1, mrsD, mrsM and mrsT genes);Herzner, A,M.等;《GenBank Database》;Accession No. AJ250862.2 *
Expression of the Lantibiotic Mersacidin in Bacillus amyloliquefaciens FZB42;Anna Maria Herzner等;《PLOS ONE》;第6卷(第7期);附图1,第8页左栏第1段第4-5行 *
Mersacidin, a new antibiotic from bacillus fermentation, isolation, purification and chemical characterization;Sukumar Chatterjee等;《THE JOURNAL OF ANTIBIOTICS》;第45卷(第6期);第832-838页 *
Mining the Genome of Bacillus velezensis VB7 (CP047587) for MAMP Genes and Non-Ribosomal Peptide Synthetase Gene Clusters Conferring Antiviral and Antifungal Activity;Saravanan R等;《Microorganisms》;第9卷(第12期);第1-18页 *
多粘类芽孢杆菌HY96-2的全基因组测序分析与生防机制的探索;程跃娟;《中国优秀硕士学位论文全文数据库》(第2020年第01期期);D046-277 *
枯草芽孢杆菌NBF809防治番茄棒孢叶斑病研究;黄大野;曹春霞;张亚妮;王开梅;饶万中义;周荣华;杨自文;;《中国蔬菜》(12);第46-50页 *

Also Published As

Publication number Publication date
CN114457102A (en) 2022-05-10

Similar Documents

Publication Publication Date Title
KR102223657B1 (en) COMPOSITION FOR PREVENTING OR TREATING Inflammatory Bowl Disease
CN111205354B (en) Signal peptide mutant for improving secretion of heterologous protein and construction method and application thereof
CN108794635B (en) Bovine lactoferricin-human lysozyme fusion protein, gene and application thereof
CN111411054B (en) Lactococcus lactis for expressing antibacterial peptide gene
KR20210041903A (en) Recombinant Acid Resistant Yeast Inhibited Lactate Metabolism and Alcohol Production and Method for Preparing Lactic Acid Using The Same
CN111333713B (en) Lactobacillus plantarum for expressing antibacterial peptide gene
KR101619863B1 (en) -Novel -glactosidase
KR20210128742A (en) Recombinant Acid Resistant Yeast Inhibited Glycerol Production and Method for Preparing Lactic Acid Using The Same
CN110592125A (en) Construction method of food-grade degraded ethanol bacillus subtilis recombinant bacteria
KR101762199B1 (en) Polypeptides with superoxide dismutase activity derived from bacillus amyloliquefaciens and preparation method thereof
WO2017010833A1 (en) Novel alpha-1,3-glucanase
CN114457102B (en) Gene expression cassette for encoding secreted Mersacidin and preparation method thereof
CN107384813B (en) Aspergillus niger strain for protein production and application thereof
CN113354718B (en) Pirfenidone precursor, expression cassette and preparation method thereof
CN109652436B (en) Recombinant lactococcus lactis strain and preparation method and application thereof
CN110591996A (en) Construction method and application of high-yield L-lysine bacillus subtilis engineering bacteria
CN110845586B (en) Secretory type grignard cyclic peptide and preparation method thereof
CN115074347A (en) Feed additive containing keratinase mutant and bile acid and application thereof
KR100427408B1 (en) The Method for the Production of Active Defensin Using a Transformed Strain of Pichia pastoris GS115/pPIDE(KCTC 1032BP)
CN114806986B (en) Genetically engineered bacterium for high-yield rocmycin as well as construction method and application thereof
CN114933644B (en) Loach antibacterial peptide Ma-sHep and application thereof
CN113755517B (en) Construction method and application of SLCG _5407 gene modified streptomyces lincolnensis
CN101735994A (en) Method for expressing bovine trypsin in lactic acid galactococcus
CN109096383B (en) Fish-derived antibacterial peptide parasin I mutant and application thereof
KR100543462B1 (en) Recombinant Bacillus expressing lactoferrin and method for preparation thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant